909 results on '"Marwick, T"'
Search Results
2. Reasons for Non-Participation in a Nurse-Led mHealth Secondary Prevention Program for Coronary Artery Disease
3. Is Personalisation of Cardiovascular Risk a Superior Approach to Engage Primary Care in the Continuation of Statin Use Over Conventional Risk Information?
4. Evaluation of the AusCVDRisk Calculator in the Detection of Atherosclerotic Burden
5. Pre-Existing Cardiovascular Disease and Post-Acute Sequalae of SARS-CoV-2
6. Improving Adherence in Primary Prevention: Is it the Image of Risk or the Personalisation of the Message That’s Important?
7. The Synergistic Effect of Cancer Survivorship in Heart Failure Risk
8. Role of Conventional Heart Failure Risk Factors in Cancer Survivors and Other At-Risk Groups
9. Heart Failure Risk in Cancer Survivorship: A Systematic Review and Meta-Analysis
10. Comparison of Available Risk Tools for HF Prediction
11. Coronary Artery Disease: Risk Difference Between Cancer Survivors and Non-Cancer Participants
12. A Newly Developed Risk Score to Predict Heart Failure Among Cancer Survivors—The CRS-HF
13. Screening for Frailty to Maximise the Effectiveness of Intervention to Reduce Readmission in Heart Failure
14. Cognitive Impairment as a Factor to Influence Development of Heart Failure
15. Can Polygenic Risk Score Predict Incidence of Heart Failure in Long Term Cancer Survivors?
16. BMI Grading for Echocardiogram Image Quality
17. An Artificial Intelligence-Guided Echocardiography in Primary Care Patients from Rural and Remote Communities: The AGILE-Echo Study
18. Growth and geographical variation in the use of cardiac imaging in Australia
19. What is the evidence status of Appropriate Use Criteria (AUC)? Insight from a matching exercise with the guidelines for echocardiography
20. Arterial stiffness, central blood pressure and body size in health and disease
21. A comparison of methods for assessing total arterial compliance
22. Chemotherapy-related cardiomyopathy: a neglected aspect of cancer survivorship
23. The diabetic, hypertensive heart: epidemiology and mechanisms of a very high-risk situation
24. Improvement of left ventricular function by lifestyle intervention in obesity: contributions of weight loss and reduced insulin resistance
25. Central blood pressure measurement may improve risk stratification
26. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies
27. A Systematic Review and Meta-analysis of Atrial Fibrillation Detection Rates in Cancer Survivors
28. Environmental Factors Influence the Natural History of Genetic Dilated Cardiomyopathy
29. High Lipoprotein(a) Does Not Improve Risk Prediction of Coronary Calcium in a Low–Intermediate Risk Cohort With a Family History of Premature Coronary Artery Disease
30. Association of Polygenic Risk With Coronary Calcium and Plaque Characteristics in People With a Family History of Coronary Artery Disease
31. Does Patient Visualisation of Coronary Atherosclerosis Improve Cardiovascular Risk, Lipids, or Blood Pressure in Asymptomatic People at Intermediate Risk?
32. Comorbidity is the Driver of Adverse Outcomes in Patients With Moderate Aortic Stenosis
33. Cardiac Function and Functional Capacity in Patients After COVID-19 Infection and Community Controls
34. Cardiac Resynchronisation Therapy: Time for Medicare to Get With the Guidelines
35. Heart Failure and Cognitive Impairment: Is it a Causal Relationship?
36. Derivation and Validation of Risk Score to Predict Mortality or Heart Failure-Related Hospitalisation Based on Clinical and Echocardiographic Factors in Moderate or Severe Aortic Stenosis
37. Reply to Morton. Heart-rate responses to exercise in patients with diabetes with acute or chronic autonomic dysfunction
38. Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)
39. Response to ‘More fuel in the obesity paradox debate’: fatness, fitness, stiffness and blood pressure
40. Diagnostic accuracy of heart-rate recovery after exercise in the assessment of diabetic cardiac autonomic neuropathy
41. Reliability of heart rate variability in patients with Type 2 diabetes mellitus
42. P440Use of strain and natriuretic peptide for distinction of familial and systemic amyloidosis
43. Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform: Report of a policy conference of the European Society of Cardiology†
44. Mechanical synchrony and survival in heart failure
45. Rationale and Design of the Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes: The SUCCOUR Trial
46. Contribution of abnormal arterial function to cardiac syndrome X: a study of pressure waveform analysis and exercise haemodynamics
47. Strain rate evaluation of phasic atrial function in hypertension
48. Effects of exercise intervention on myocardial function in type 2 diabetes
49. Prognosis of patients with ischaemic cardiomyopathy after coronary revascularisation: relation to viability and improvement in left ventricular ejection fraction
50. Evolution and outcome of diastolic dysfunction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.